Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter McIntyre

Showing results (161-170 of 235) with videos related to

Pageof 24
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 24, 2014
HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination programSepehr N Tabrizi, Julia M L Brotherton, Matthew P Stevens, et al.
Vaccine|July 2, 2011
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trialsPierre Van Damme, Peter McIntyre, Emmanuel Grimprel, et al.
Communicable Diseases Intelligence Quarterly Report|March 1, 2005
Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002Julia Brotherton, Peter McIntyre, Michele Puech, et al.
Influenza and Other Respiratory Viruses|July 9, 2024
Comparison of the Burden and Temporal Pattern of Hospitalisations Associated With Respiratory Syncytial Virus (RSV) Before and After COVID-19 in New ZealandNikki Turner, Nayyereh Aminisani, Sue Huang, et al.
Vaccine|October 4, 2015
Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection modelAzadeh Safarchi, Sophie Octavia, Laurence Don Wai Luu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2016
Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income CountriesAjoke Sobanjo-Ter Meulen, Philippe Duclos, Peter McIntyre, et al.
Journal of the Pediatric Infectious Diseases Society|May 31, 2022
Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Medically At-Risk Children in Australia: A Record Linkage StudyAlamgir Kabir, Anthony T Newall, Deborah Randall, et al.
Vaccine|July 28, 2023
Incremental effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia hospitalisation among Australian Indigenous children: A record linkage studyAlamgir Kabir, Deborah Randall, Anthony T Newall, et al.
Communicable Diseases Intelligence (2018)|July 19, 2019
Influenza vaccination coverage in a population-based cohort of Australian-born Aboriginal and non-Indigenous older adultsAmalie Dyda, Surendra Karki, Marlene Kong, et al.
Vaccine|June 28, 2016
Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model studyAzadeh Safarchi, Sophie Octavia, Laurence Don Wai Luu, et al.
Pageof 24

Showing results (161-170 of 235) with videos related to

Sort By:
Pageof 24
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 24, 2014
HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination programSepehr N Tabrizi, Julia M L Brotherton, Matthew P Stevens, et al.
Vaccine|July 2, 2011
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trialsPierre Van Damme, Peter McIntyre, Emmanuel Grimprel, et al.
Communicable Diseases Intelligence Quarterly Report|March 1, 2005
Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002Julia Brotherton, Peter McIntyre, Michele Puech, et al.
Influenza and Other Respiratory Viruses|July 9, 2024
Comparison of the Burden and Temporal Pattern of Hospitalisations Associated With Respiratory Syncytial Virus (RSV) Before and After COVID-19 in New ZealandNikki Turner, Nayyereh Aminisani, Sue Huang, et al.
Vaccine|October 4, 2015
Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection modelAzadeh Safarchi, Sophie Octavia, Laurence Don Wai Luu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2016
Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income CountriesAjoke Sobanjo-Ter Meulen, Philippe Duclos, Peter McIntyre, et al.
Journal of the Pediatric Infectious Diseases Society|May 31, 2022
Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Medically At-Risk Children in Australia: A Record Linkage StudyAlamgir Kabir, Anthony T Newall, Deborah Randall, et al.
Vaccine|July 28, 2023
Incremental effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia hospitalisation among Australian Indigenous children: A record linkage studyAlamgir Kabir, Deborah Randall, Anthony T Newall, et al.
Communicable Diseases Intelligence (2018)|July 19, 2019
Influenza vaccination coverage in a population-based cohort of Australian-born Aboriginal and non-Indigenous older adultsAmalie Dyda, Surendra Karki, Marlene Kong, et al.
Vaccine|June 28, 2016
Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model studyAzadeh Safarchi, Sophie Octavia, Laurence Don Wai Luu, et al.
Pageof 24